Clinical Strategies for Preserving Fertility in Male Cancer Patients - Scorecard - MDSpire
Advertisement
Clinical Strategies for Preserving Fertility in Male Cancer Patients
Urologist Justin Dubin, M.D., director of Men’s Sexual Health at Baptist Health Miami Cancer Institute, emphasizes that fighting cancer and preserving fertility are not mutually exclusive.
Clinical Scorecard: Clinical Strategies for Preserving Fertility in Male Cancer Patients
At a Glance
Category
Detail
Condition
Male infertility related to cancer treatments
Key Mechanisms
Gonadotoxic effects of chemotherapy, radiation, and immunotherapy impair spermatogenesis and sexual health
Target Population
Male cancer patients undergoing gonadotoxic therapies
Care Setting
Oncology and interdisciplinary reproductive health clinics
Key Highlights
Early assessment of fertility risk and patient family planning goals before initiating cancer treatment is critical.
Sperm banking prior to treatment remains the primary and most effective fertility preservation method.
Post-treatment options include advanced sperm retrieval techniques and assisted reproductive technologies such as IVF and ICSI.
Guideline-Based Recommendations
Diagnosis
Incorporate reproductive health assessments and fertility goal inquiries into initial oncology consultations.
Add fertility-related prompts to patient intake forms to systematically identify preservation needs.
Management
Refer patients desiring future fertility to reproductive specialists promptly before starting gonadotoxic therapies.
Offer sperm banking to all eligible male patients prior to cancer treatment initiation.
Avoid traditional testosterone replacement therapy in men desiring fertility; use alternative endocrine therapies that preserve spermatogenesis.
Refer men with hypogonadism and fertility concerns to men’s health specialists for tailored management.
Monitoring & Follow-up
Establish long-term survivorship protocols to monitor sexual health, hypogonadism, and fertility status post-treatment.
Counsel patients to wait at least one year after completion of chemotherapy, radiation, or immunotherapy before attempting conception.
Provide early sexual health specialist care to manage erectile dysfunction, ejaculatory disorders, and hormonal assessments.
Risks
Gonadotoxic cancer therapies can cause temporary or permanent infertility.
Traditional testosterone replacement therapy suppresses the hypothalamic-pituitary-gonadal axis, leading to infertility.
Delays in fertility preservation discussions may result in missed opportunities for sperm banking.
Patient & Prescribing Data
Male cancer patients undergoing chemotherapy, radiation, or immunotherapy
Early sperm banking improves patient satisfaction and psychological outcomes; alternative endocrine therapies can manage hypogonadism without compromising fertility.
Clinical Best Practices
Systematically ask every male cancer patient about future family planning desires at initial consultation.
Integrate fertility goal prompts into oncology intake workflows to ensure timely referrals.
Prioritize sperm banking before treatment to preserve reproductive potential.
Utilize advanced sperm retrieval and assisted reproductive technologies for post-treatment infertility.
Avoid traditional testosterone replacement therapy in men wishing to maintain fertility; use fertility-sparing endocrine treatments.
Implement long-term follow-up protocols addressing sexual health and fertility recovery.
Educate oncology teams to balance immediate cancer treatment with holistic survivorship care.